DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Saturday, 21 May 2016

DR BANSI LAL




DR BANSI LAL
https://plus.google.com/110119093992288825676/about
drbansilal@gmail.com
https://www.linkedin.com/in/dr-bansi-lal-2437054
https://www.facebook.com/bansi.lal.142





Dr. Bansi Lal



Dr. Bansi Lal, is the President and Head of Department of our Research and Development team. Dr. Bansi Lal has obtained a Bachelors degree in Science from Jammu and Kashmir University and a Masters degree in Science from Jammu and Kashmir University, Doctorate in medicinal chemistry from Central Drug Research Institute, Lucknow, Post Doctoral Research Associate in organic chemistry from Steven's Institute of Technology, USA and Post Doctoral Research Fellowship in organic chemistry from Indiana University, RIA University, USA. Dr. Bansi Lal has 37 years of experience and, prior to joining our Company, was associated with Hoechst Marion Roussel Limited and Nicholas Piramal Research Centre. Dr. Bansi Lal core areas of competence are drug discovery, synthetics chemistry, patents and administration.

 

 

Experience


PRESIDENT(R&D)
   Dr. Bansi Lal joined Calyx in 2005 as President – R&D. A distinguished Scientist having work experience of 35 years in Drug Discovery & Synthesis Chemistry.

 





 

 

 

Education







 


Drug discovery conference at Sri Chatrapati Shivaji Maharaj Mahavidyalaya, Shrigonda, श्रीगोंदा, Maharashtra, India, 27,28 Jan 2016

 
 Principal, Dr. Shamrao Lawande
Sri Chatrapati Shivaji Maharaj Mahavidyalaya, shrigonda, श्रीगोंदा, Maharashtra, India


Drug discovery conference at Sri Chatrapati Shivaji Maharaj Mahavidyalaya, shrigonda, श्रीगोंदा, Maharashtra, India, 27,28 jan 2016.......,Myself  Anthony Melvin Crasto
With Dr Bansi Lal, Vilas Sudrik , Dr.Sachindra Patil(Founder Kanashi Biotech,Pune), Prin. Dr. Shamrao Lawande.



 Maharashtrian thali, meethi chi bhaji..........This was arranged in bhojanalaya, girls hostel accomodating 300 plus girls in hostel , in a strength of 3000 students, ratio being 50 50 for boys and girls — with Shamrao Lawande and Bansi Lal.



 
 Dr.Sachindra Patil(Founder Kanashi Biotech,Pune)

Map of shrigonda city
Shrigonda
City in India
Shrigonda is an old city and a municipal council in Ahmednagar district in the Indian state of Maharashtra. The place is described as Santanchi Punyabhumi. Wikipedia
Weather: 32°C, Wind NE at 5 km/h, 20% Humidity
Local time: Saturday 3:25 PM
Population: 26,331 (2001)




 At 27 Jan.2016 Conference was very nice on "Advances in Drug discovery and designing" opened by Pune University Vice Chancellor Dr.Wasudev Gade sir.at Chhatrapati college Shrigonda,thanks to Principal Dr.S.P.Lawande sir for guiding to arrange the seminar.
Also on 28 Jan.2016 second whole day industry experts that is Dr.Crasto from glenmark, Dr.Bansi Lal from Ex Head, Piramal healthcare and Dr.Patil from Sai advantinium very nicely shared their practical approach in drug discovery and guided PG students and all participants.
Co-ordinator-Prof.Vilas Sudrik(CSIR-NET)







 Vilas Sudrik



 
 
 


Map of Sri Pratap College
Sri Pratap College 
College in Srinagar
Sri Pratap College Srinagar commonly known as SP College is an academic and professional college in Kashmir. It is the oldest institute of higher education in Kashmir. Wikipedia
Address: S.P College, Kothi Bagh, Srinagar
Phone: 0194 247 6828
Founded: 1905
 

///////








.....


DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE



Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com

Friday, 20 May 2016

Alisa Hagen


Alisa Hagen
M.Sc. Student.
Institute of Chemistry and the Center for Nanoscience and Nanotechnology
Jerusalem, 91904.
Israel.
Email: alisa.hagen@mail.huji.ac.il
Tel.: +972-2-6586985
FAX: +972-2-6584148
https://il.linkedin.com/in/alisa-hagen-9b142192
https://www.facebook.com/alisa.hagen


The Banin Group
/////

Thursday, 19 May 2016

Liron Oskar

Liron Oskar


Liron Oskar

Research and Development Chemist at Taro Pharmaceutical Industries

links


Experience




Research and Development Organic Chemist

Taro Pharmaceutical Industries
 – Present (1 year 5 months)Haifa, Israel



Laboratory Teaching Assistant

Technion - Israel Institute of Technology
 –  (1 year 11 months)

Education



Technion - Israel Institute of Technology

Bachelor's degree, Chemistry

.

 





M.Sc Thesis

M.Sc StudentLiron Oskar
SubjectMerging Allylic Carbon-Hydrogen and Carbon-Carbon Bond
Activations en-route to Sophisticated
Molecular Framework
DepartmentDepartment of Chemistry
SupervisorFull Professors Marek Ilan
Full Thesis textFull thesis text - English Version
http://www.graduate.technion.ac.il/Theses/Abstracts.asp?Id=29080

Abstract

Recently, our group has developed the zirconocene-mediated ring opening of alkylidenecyclopropanes (ACPs) and w-ene cyclopropanes derivatives, via a unique and selective merging of allylic carbon-hydrogen and carbon-carbon bond activations, leading to bismetallated zirconocene complex. The addition of two different electrophiles gives bisfunctionalized acyclic molecules in excellent yields. By diversifying the nature of the two electrophiles, two stereogenic centers were created with high diastereoselectivity.
In this context, we proposed to enlarge the scope of this process by creating three stereogenic centers in an acyclic product via a one-pot sequence, while studying the diastereoselectivity.
Since zirconocene-mediated ring opening was done with stoichiometric amount of zirconocene complex, we tried to develop a catalytic process for the ring cleavage applied on ACPs derivatives, based on the successful catalytic carbozirconation on multiple bonds.
A deeper mechanistic understanding of the combined allylic carbon-hydrogen and carbon-carbon bond activations pathway was also proposed, using labeled experiments.
Finally, we applied our zirconocene-mediated ring opening methodology to the synthesis of the two enantiomers of deuterated neopentane: the smallest enantiomerically enriched hydrocarbons that possess an all-carbon quaternary stereocenter, that is, a carbon center with four different non-hydrogen substituents. Using advanced and sensitive methods, we successfully determined their absolute configuration.





http://indianexpress.com/article/business/business-others/sun-pharma-shares-at-record-high-hopes-of-higher-sales-in-key-cancer-drug/


///////

Jigisha Varia

Jigisha Varia RAC (US).


Jigisha Varia RAC (US)

Associate Director Regulatory Affairs at eVenus Pharmaceutical Laboratories, Inc.


 links

 https://www.linkedin.com/in/jigisha-varia-rac-us-09636014





xperience



Associate Director Regulatory Affairs

eVenus Pharmaceutical Laboratories Inc.
– Present (4 months)Greater New York City Area


Senior Manager Regulatory Affairs

eVenus Pharmaceutical Laboratories, Inc.
(9 months)Greater New York City Area


Manager Regulatory Affairs

SUN PHARMA
(1 year 10 months)Greater New York City Area


Senior Associate, Regulatory affairs

SUN PHARMA
(2 years 1 month)greater detroit area


Senior Regulatory affairs/Product development

Revogenex Inc
(2 years 5 months)


Senior Research scientist

Alembic
(4 years 2 months)


Research associate

SUN PHARMA
(7 months)



Education


The Maharaja Sayajirao University of Baroda

Maters in pharmaceutical technology, pharmaceutics


/////////